weight loss semaglutide covington New Orleans | Medical In Metairie, LA Medical Weight Loss - Timeless

What started as a class of medications for type 2 diabetes moved into weight loss, and has since expanded into treating fatty liver disease (also known as metabolic dysfunction-associated steatohepatitis, or MASH), specific cardiovascular diseases, obstructive sleep apnea, and the list continues to grow

Unlike existing medications, it stimulates three distinct hormonal pathways with synergistic metabolic benefits

13 (12), e238315

Tirzepatide (Mounjaro) a dual GLP-1/GIP agonist licensed in the UK for type 2 diabetes and, following a positive NICE technology appraisal (TA1026), recommended for weight management in eligible adults within specialist services